Abstract
This chapter discusses the genetics, metabolic actions, substrates, inducers, and inhibitors of cytochrome P450 1A2
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wang B, Zhou SF. Synthetic and natural compounds that interact with human cytochrome P450 1A2 and implications in drug development. Curr Med Chem. 2009;16(31):4066–218.
Zhou SF, et al. Insights into the structure, function, and regulation of human cytochrome P450 1A2. Curr Drug Metab. 2009;10(7):713–29.
Zhou SF, et al. Insights into the substrate specificity, inhibitors, regulation, and polymorphisms and the clinical impact of human cytochrome P450 1A2. AAPS J. 2009;11(3):481–94.
Skarke C, et al. Rapid genotyping for relevant CYP1A2 alleles by pyrosequencing. Eur J Clin Pharmacol. 2005;61(12):887–92.
Schweikl H, et al. Expression of CYP1A1 and CYP1A2 genes in human liver. Pharmacogenetics. 1993;3(5):239–49.
Harris R, Jang G, Tsunoda S. Dietary effects on drug metabolism and tranport. Clin Pharmacokinet. 2003;42(13):1071–88.
Zevin S, Benowitz NL. Drug interactions with tobacco smoking. An update. Clin Pharmacokinet. 1999;36(6):425–38.
Parikh A, Josephy PD, Guengerich FP. Selection and characterization of human cytochrome P450 1A2 mutants with altered catalytic properties. Biochemistry. 1999;38(17):5283–9.
Desai HD, Seabolt J, Jann MW. Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective. CNS Drugs. 2001;15(6):469–94.
Hoffmann D, Djordjevic M, Hoffmann I. The changing cigarette. Prev Med. 1997;26(4):427–34.
Callaghan JT, et al. Olanzapine. Pharmacokinetic and pharmacodynamic profile. Clin Pharmacokinet. 1999;37(3):177–93.
Kroon LA. Drug interactions with smoking. Am J Health Syst Pharm. 2007;64(18):1917–21.
Faber M, Jetter A, Fuhr U. Assessment of CYP1A2 activity in clinical practice: why, how, and when? Basic Clin Pharmacol Toxicol. 2005;97:125–34.
Lobo ED, et al. In vitro and in vivo evaluations of cytochrome P450 1A2 interactions with duloxetine. Clin Pharmacokinet. 2008;47(3):191–202.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Roussel, D., Hagn, E., Dull, R.O. (2015). CYP1A2: The Switch-hitter. In: Marcucci, C., et al. A Case Approach to Perioperative Drug-Drug Interactions. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7495-1_8
Download citation
DOI: https://doi.org/10.1007/978-1-4614-7495-1_8
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-7494-4
Online ISBN: 978-1-4614-7495-1
eBook Packages: MedicineMedicine (R0)